The congress has been developed with advice from leading experts in the field of stem cells and regenerative medicine. Our advisory board comprises individuals at the forefront of stem cell research and development.

	Dr Chris Mason Director, Regenerative Medicine Bioprocessing Unit University College London At the forefront of this field, Chris is an alumnus of Imperial College and St. Thomas’ Hospital and is a Fellow of the Royal College of Surgeons as well as holding a PhD in Biochemical Engineering (UCL.) Chris has expertise in industrial consultancy and technology companies and is co-organiser of the London Regenerative Medicine Network.		Hugh Ilyine Chief Operating Officer Stem Cell Sciences When Hugh joined Stem Cell Sciences in 2000 he brought extensive experience in developing, registering, manufacturing and distributing products in the agrochemical and bioscience sector. Hugh has managerial and directorial experience on both a national and international level and in his current role he oversees the Worldwide business operations of Stem Cell Sciences.
	Dr Stephen Minger Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases King's College London Stephen was granted one of the first licenses for the derivation of human ES cells and his group generated the first human ES cell line in the UK. Stephen collaborates with UK clinical groups and is a co-organiser of the London Regenerative Medicine Network.		Dr Tim Allsopp Chief Scientific Officer Stem Cell Sciences After 12 years as a leading academic with a developing interest in stem cell biology Tim joined Stem Cell Sciences Ltd to utilize pluripotent, embryonic stem cells in the discovery of unique human disease treatments and cures. Current responsibilities include directing the research in ES biology, development of ES-based technologies for applications in gene & drug discovery and business development.